Bill > S612

This bill aims to promote healthcare access and affordability for patients. The key provisions are: 1. It requires health insurance carriers to annually certify that they made available to insured individuals at least 80% of the estimated rebates they received from pharmaceutical manufacturers and other parties during the prior plan year by reducing the amount of cost-sharing charged to the insured at the point of sale. Neither the insured nor the carrier is responsible for any difference between the estimated and actual rebate amounts, as long as the estimates were calculated in good faith. 2. It requires carriers to report annually to the state insurance commissioner on their compliance with the rebate pass-through requirement, and authorizes the commissioner to impose fines of up to $5,000 per day for non-compliance. 3. It directs the state's Health Policy Commission and the Secretary of Health and Human Services to analyze and report on anticipated barriers to patient access to cell and gene therapy treatments, particularly for MassHealth (Medicaid) beneficiaries and other vulnerable populations, and to propose policy solutions to address any identified barriers.

Business and Industry, Health and Social Services

https://malegislature.gov/Bills/193/S612